Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Filings indexed 1,067 across all filing types
Latest filing 2026-04-26 Interim / Quarterly Rep…
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
AN1 - Appendix 4C & Activity Report for Q3 FY2026 7 pages 578.7KB
Interim / Quarterly Report Classification · 95% confidence The document is an 'Appendix 4C' quarterly cash flow report for Anagenics Limited, which is a standard regulatory filing required by the Australian Securities Exchange (ASX) for entities subject to Listing Rule 4.7B. It contains detailed financial data regarding cash flows, operating activities, and financing facilities for the quarter ended 31 March 2026. While it includes a brief activity report, the core of the document is the standardized financial statement required for quarterly reporting. Therefore, it is classified as an Interim/Quarterly Report (IR). Q3 2026
2026-04-26 English
Notification of cessation of securities - AN1 4 pages 14.7KB
Share Issue/Capital Change Classification · 85% confidence The document is an ASX Appendix 3H form notifying the cessation (expiry) of unquoted equity options (3,500,000 securities) and detailing changes to issued capital. It is a formal announcement of a capital change rather than an earnings release, call transcript, or AGM material. This fits the "Share Issue/Capital Change" category (SHA).
2026-04-16 English
AN1 - Director Appointment 1 page 234.4KB
Board/Management Information Classification · 100% confidence The document announces the appointment of a new Non-Executive Director, Josh Gordon, to the company's board. It provides background information on the appointee and welcomes him to the board. There is no financial data, no mention of a report or meeting materials, no voting results, and no other regulatory or financial disclosures. This fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2026-03-01 English
Appendix 3X MR JOSHUA GORDON 2 pages 163.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of a newly appointed director, including shares and options held. This type of document is a notification of personal share transactions or holdings by a company director. It is not a financial report, earnings release, or management report. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director interests, confirming it is not a broader regulatory or financial filing.
2026-03-01 English
Change of Director's Interest Notice 2 pages 274.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed information about a director's shareholding changes, including dates, number of shares acquired, and consideration paid. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure related to insider trading or director share transactions. The content is specific to a director's personal share transactions and does not include financial results, management discussion, or other report types. Therefore, it fits the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3620 characters, consistent with a detailed notice rather than a full report or announcement. Hence, the correct classification is DIRS with high confidence.
2026-02-26 English
Appendix 4D 1H FY26 DEC 2025 1 page 180.0KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4D - Half Year Report for six months ended 31 December 2025' and contains financial results for the half year period ending 31 December 2025. It includes revenue, profit/loss figures, net tangible assets, and explanatory notes about the company's performance. It references a half-year financial report and an Independent Auditor's Review Report included in the half-year financial report. The document is a comprehensive financial report for a period shorter than a full fiscal year, containing substantive financial data and analysis. The length is 2459 characters, which is relatively short but typical for an Appendix 4D half-year report announcement in Australia. Appendix 4D is a recognized half-year financial report format under ASX rules. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.